Showing results (71-80 of 119) with videos related to

Sort By:
Pageof 12
The Lancet. Oncology|July 10, 2022
Niraparib plus nivolumab or niraparib plus ipilimumab in patients with platinum-sensitive advanced pancreatic cancer: a randomised, phase 1b/2 trialKim A Reiss, Rosemarie Mick, Ursina Teitelbaum, et al.
Oncoimmunology|March 14, 2013
Autologous lysate-pulsed dendritic cell vaccination followed by adoptive transfer of vaccine-primed ex vivo co-stimulated T cells in recurrent ovarian cancerLana E Kandalaft, Daniel J Powell, Cheryl L Chiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 15, 2016
Dendritic Cell Vaccination Enhances Immune Responses and Induces Regression of HER2<sup>pos</sup> DCIS Independent of Route: Results of Randomized Selection Design TrialLea Lowenfeld, Rosemarie Mick, Jashodeep Datta, et al.
Clinical Lung Cancer|April 8, 2022
Phase II Trial of Combination Nab-paclitaxel and Gemcitabine in Non-squamous Non-small Cell Lung Cancer After Progression on Platinum and PemetrexedChristine A Ciunci, Jacob B Reibel, Tracey L Evans, et al.
JAMA Oncology|July 12, 2019
Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 TrialJoshua M Bauml, Rosemarie Mick, Christine Ciunci, et al.
Carcinogenesis|November 9, 2018
IMP1 3' UTR shortening enhances metastatic burden in colorectal cancerSarah F Andres, Kathy N Williams, Jacqueline B Plesset, et al.
Blood|January 7, 2017
Clinical and immunologic impact of CCR5 blockade in graft-versus-host disease prophylaxisRyan H Moy, Austin P Huffman, Lee P Richman, et al.
Journal of Environmental Pathology, Toxicology and Oncology : Official Organ of the International Society for Environmental Toxicology and Cancer|March 29, 2006
Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancerKosmas Verigos, Diana C Hsiung Stripp, Rosemarie Mick, et al.
Journal of Hematotherapy & Stem Cell Research|June 14, 2003
Homocysteine and prothrombin fragment 1+2 levels in patients with veno-occlusive disease after stem cell transplantationJohn Gerecitano, Clarissa Mathias, Rosemarie Mick, et al.
Oncoimmunology|March 1, 2021
A stratified phase I dose escalation trial of hypofractionated radiotherapy followed by ipilimumab in metastatic melanoma: long-term follow-up and final outcomesAmit Maity, Rosemarie Mick, Ramesh Rengan, et al.
Pageof 12